Benchmark Maintains Buy on Transphorm, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst David Williams maintains a Buy rating on Transphorm (NASDAQ:TGAN) and keeps the price target at $8.
October 13, 2023 | 3:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst David Williams maintains a Buy rating on Transphorm (NASDAQ:TGAN) and keeps the price target at $8.
The news directly pertains to Transphorm (TGAN) as the Benchmark analyst maintains a Buy rating on the company and keeps the price target at $8. This could potentially have a positive impact on the stock as it indicates the analyst's confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100